ArticleBMC infectious diseases2025
Validation of charcot's triad and Tokyo guidelines 2018 as a diagnostic tool for acute ascending cholangitis secondary to a liver cystic echinococcosis.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association between anion gap trajectories and mortality in patients with acute cholangitis: a cohort study.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThis study aimed to evaluate the diagnostic accuracy of Charcot's triad (CT) and the Tokyo Guidelines 2018 (TG18) for acute ascending cholangitis (AAC) secondary to liver cystic echinococcosis (LEC) rupture in the biliary tree.
methodsThis retrospective multicenter study was conducted between January 2016 and December 2021. The diagnostic performance of CT and TG18 was evaluated using sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and area under the ROC curve.
resultsAmong 1643 patients, 133 were diagnosed with AAC (8.1%). Concerning CT, the analytical study showed that the incomplete form had a sensitivity of 28.6%, specificity of 91.9%, PPV of 36%, and NPV of 89%. The complete form had a sensitivity, specificity, PPV, and NPV of 25.4%, 97.5%, 61.5%, and 89.1%, respectively. For TG18, the suspected/definite form had a sensitivity, specificity, PPV, and NPV of 74.6%, 68.2%, 22.1%, and 93.5%, respectively. The definite form had a sensitivity, specificity, PPV, and NPV of 65.1%, 88.4%, 47.1%, and 94.1%, respectively. The Suspected form was estimated at an AUC of 0.447, with a non-significant p-value.
conclusionsThis research emphasizes the complexity of AAC diagnosis and the limitations of current diagnostic tools. TG18, especially in its definite form, can effectively rule out AAC, whereas CT, despite its low sensitivity, remains useful due to its high specificity. The findings advocate further research to refine the existing diagnostic methods and develop new tools.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.